[1-(3-phenoxypropyl)-1H-benzimidazol-2-yl]methanol, 95.0%, 5g

tert-Butyl 3-ethyl-3-(hydroxymethyl)azetidine-1-carboxylate, 95.0%, 250mg

5-(((tert-Butoxycarbonyl)amino)methyl)-2-chlorobenzoic acid, 95%, 1g

(2-Isopropoxy-5-(trifluoromethyl)phenyl)boronic acid, 95.0%, 10g

2-(Hydroxymethyl)-12-crown 4-Ether>95.0%(GC)5g

(4-Allyl-2-methoxyphenoxy)acetic Acid>98.0%(GC)(T)5g

1,2-Dicloroetano, mínimo 99 %, para síntesis, 2,5 L, envase de vidrio

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 1g

5-Methyl-3-(pyrimidin-2-yl)-1,2,4-oxadiazole, 250mg

Boc-NH-PEG7-acid, 1g

4-Cyclopentylmorpholine, 95.0%, 1g

3-(4-Pyridyl)acrylic Acid>97.0%(GC)(T)5g

2,4-Dimethylbenzene-1,3-diamine, 95+%, 250mg